`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`
`v.
`
`
`POZEN INC. and HORIZON PHARMA USA, INC.,
`Patent Owners.
`
`___________
`
`
`Case IPR2017-01995
`Patent 9,220,698
`
`___________
`
`
`PATENT OWNER EXHIBIT LIST
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`EXHIBIT NO.
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`Case No. IPR2017-01995
`Patent No. 9,220,698
`
`PATENT OWNER EXHIBIT LIST
`
`BRIEF DESCRIPTION
`Gabriel, S.E., et al., “Risk for Serious Gastrointestinal
`Complications Related to Use of Nonsteroidal Anti-
`inflammatory Drugs,” Annals of Internal Medicine, Vol.
`115, No. 10, pp. 787-796 (1991) (“Gabriel”)
`
`Cryer, B. and Feldman, M., “Effects of Nonsteroidal Anti-
`inflammatory Drugs on Endogenous Gastrointestinal
`Prostaglandins and Therapeutic Strategies for Prevention
`and Treatment of Nonsteroidal Anti-inflammatory Drug-
`Induced Damage,” Archives of Internal Medicine, Vol.
`152, pp. 1145-1155 (1992) (“Cryer”)
`
`Fries, J.F., et al., “Nonsteroidal Anti-Inflammatory Drug-
`Associated Gastropathy: Incidence and Risk Factor
`Models,” The American Journal of Medicine, Vol. 91, pp.
`213-222 (1991) (“Fries”)
`
`Second Amended Complaint for Patent Infringement,
`Horizon Pharma, Inc. v. Mylan Pharmaceuticals Inc., Civil
`Action No. 2:15-cv-03327 (D.N.J. Feb. 10, 2016)
`
`Answer to Second Amended Complaint, Separate Defenses,
`And Counterclaims by Defendants Mylan Pharmaceuticals
`Inc., Mylan Laboratories Limited and Mylan Inc. , Horizon
`Pharma, Inc. v. Mylan Pharmaceuticals Inc., Civil Action
`No. 2:15-cv-03327 (D.N.J. Feb. 19, 2016)
`
`Plaintiffs’ Answer to Defendants’ Counterclaims to Second
`Amended Complaint, Horizon Pharma, Inc. v. Mylan
`Pharmaceuticals Inc., Civil Action No. 2:15-cv-03327
`(D.N.J. Mar. 7, 2016)
`
`157 Cong. Rec. S5429 (daily ed. Sept. 8, 2011) (statement
`of Sen. Kyl)
`
`
`
`
`
`
`Date: December 12, 2017
`
`
`
`
`
`
`Case No. IPR2017-01995
`Patent No. 9,220,698
`
`Respectfully submitted,
`/Thomas A. Blinka/
`Thomas A. Blinka, Ph.D.
`Reg. No. 44,541
`Counsel for Patent Owner
`
`
`BY:
`
`
`
`
`
`
`Case No. IPR2017-01995
`Patent No. 9,220,698
`
`CERTIFICATION OF SERVICE UNDER 37 C.F.R. § 42.6(e)
`
`I, Thomas A. Blinka, hereby certify that on this 12th day of December 2017,
`
`
`
`
`
`the foregoing Patent Owner Exhibit List was served electronically via email on the
`
`following:
`
`Brandon M. White
`bmwhite@perkinscoie.com
`700 13th St., NW Suite 600
`Washington, DC 20005
`
`Emily Greb
`egreb@perkinscoie.com
`One East Main St., Suite 201
`Madison, WI 53703
`
`
`
`Date: December 12, 2017
`
`
`
`
`
`BY:
`
`
`/Thomas A. Blinka/
`Thomas A. Blinka, Ph.D.
`Reg. No. 44,541
`Counsel for Patent Owner
`
`
`
`